When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ALXN - European advisory group backs Alexion Ultomiris for aHUS
Alexion Pharmaceuticals Inc.
The European Medicines Agency's advisory group CHMP has adopted a positive opinion recommending marketing authorization for Alexion Pharmaceuticals' (NASDAQ:ALXN) ULTOMIRIS (ravulizumab) for the treatment of patients with a body weight of 10 kg or above with atypical hemolytic uremic syndrome (aHUS) who are complement inhibitor treatment-naïve or have received SOLIRIS (eculizumab) for at least 3 months and have evidence of response to eculizumab.
More news on: Alexion Pharmaceuticals, Inc., Healthcare stocks news,